Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Credit card points can unlock a variety of rewards, from travel to cashback. Discover the possibilities and make the most of your points.
28,188 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
The billionaire bill gates' foundation recently remade its public equity lineup, selling its Microsoft stake and conc...
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
AI progress hinges not just on GPUs but on the speed and efficiency of data delivery. This deep dive explains why opt...
A 78-year-old retiree weighs safe, steady income options for a disabled heir with $111K in savings, as rates rise and...
SpaceX eyes Cursor AI in a deal that could redefine tech investing. This analysis explains why spacex's acquisition c...
A thorough, original take on Eastern (EML) 2025 earnings, spotlighting Q4 results, margin trends, and guidance. Learn...
Google is pursuing a hardware-first approach to running Gemini's AI stack. This article breaks down what a dedicated ...
Investors are watching a potential shift at HubSpot as AI features expand across its platform. This guide breaks down...
A surge in AI workloads is testing chipmakers worldwide. This piece explains why tsmc can't make chips fast enough, w...
NuScale Power faced a sharp February sell-off as project delays, funding needs, and analyst downgrades weighed on the...
A bold plan unfolds as a European crypto treasury targets triple BTC holdings by buying two specialist firms. The mov...